Biobank Equipment Market—By Product Type: Sample Storage Systems, Sample Preparation Equipment, Biobank Freezers, Consumables, Software; By Application: Research & Development, Drug Discovery, Regenerative Medicine, Disease Management; By End-User: Research Institutes, Hospitals, Biotechnology Companies, Pharmaceutical Companies; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
Market Overview
The biobank equipment market is growing steadily as biorepositories expand their infrastructure to support precision medicine, clinical research, genomics, and biomarker discovery. Biobanks store biological samples such as tissues, DNA, RNA, blood, and cells, requiring robust equipment for cryopreservation, inventory management, labeling, and contamination control. Rising investments in genomics, personalized healthcare, and public health research—especially after the COVID-19 pandemic—are driving demand for ultra-low temperature (ULT) freezers, liquid nitrogen tanks, automated sample handling, and laboratory information management systems (LIMS).
Public-private consortia, national biobank initiatives, and commercial CROs are all key end users driving equipment upgrades and new installations globally.
Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
2.01 |
Driven by national genomic projects and academic research expansion |
|
2024 |
3.43 |
Integration with AI-enabled LIMS and automation technologies |
|
2031 |
6.74 |
CAGR 9.8% (2024–2031) |
As precision medicine and big data integration grow, the biobank equipment market is expected to surpass USD 6.7 billion by 2031.
Primary Market Drivers
• Expansion of national and regional biobanking programs for disease research
• Growing demand for ULT storage in cancer, neurology, and infectious disease biorepositories
• Adoption of automated sample handling systems to reduce contamination and enhance throughput
• Increasing use of LIMS and AI-based inventory management platforms
• Private investment and pharmaceutical collaboration in bio-storage logistics
Market Challenges
• High capital and maintenance costs of cryogenic equipment
• Strict temperature validation and regulatory compliance requirements
• Risk of sample degradation due to power outages or equipment failure
• Variability in standardization across international biobank facilities
Competitive Landscape
|
Company / Organization |
2024 Share |
Core Strengths |
Recent Moves |
|
Thermo Fisher Scientific |
24 % |
ULT freezers, cryo storage, LIMS integration |
Released smart freezer with IoT monitoring (Q4 2024) |
|
PHC Holdings (formerly Panasonic Biomedical) |
18 % |
Eco-friendly -86°C ULT systems |
Launched energy-efficient twin-guard freezer (Q1 2025) |
|
Hamilton Company |
15 % |
Automated sample storage and handling systems |
Expanded European biobank automation centers (Q2 2024) |
|
Brooks Life Sciences (Azenta) |
14 % |
Biorepository design, RFID sample tracking |
Acquired automated LIMS provider (Q3 2024) |
|
Others (So-Low, BioLife Solutions, Haier Biomedical, Stirling Ultracold) |
29 % |
Regional suppliers and mid-size lab automation vendors |
Increasing participation in hospital biobank projects |
Detailed Market Segmentation
By Equipment Type
• ULT Freezers – 31 %
• Cryogenic Tanks & Vials – XX %
• Sample Preparation Workstations – XX %
• Automated Storage Systems – XX %
• LIMS & Tracking Solutions – XX %
By Sample Type
• Blood & Plasma – 36 %
• DNA & RNA – XX %
• Tissues & Organs – XX %
• Cells & Stem Cells – XX %
• Others (Saliva, Urine, Microbiome) – XX %
By End User
• Academic & Research Institutes – 38 %
• Pharma & Biotech Companies – XX %
• Hospitals & Clinical Labs – XX %
• Government Biobanks – XX %
Regional Analysis
• North America (39%) – Dominates due to NIH funding and large academic centers
• Europe (XX%) – EU-backed biobank consortia and strong adoption of energy-efficient equipment
• Asia-Pacific (XX%) – Rapidly expanding genomic programs in China, South Korea, and India
• Latin America & MEA (7%) – Growth driven by cancer research programs and international partnerships
Technology and Innovation
• IoT-enabled freezer monitoring for continuous data logging
• Robotic sample sorters and retrieval units for high-throughput laboratories
• Blockchain-based chain-of-custody tracking
• RFID and barcoded vials for seamless integration with LIMS
• Low-energy Stirling engine-based cooling systems
Regulatory Environment
• WHO and OECD guidelines on biobank governance and equipment validation
• U.S. FDA and EMA regulations on biologic storage and traceability
• ISO 20387 standard for biobanking—emphasizing quality and safety
• GDPR compliance for LIMS and data security in EU-based biobanks
Recent Developments (Q4 2023 – Q2 2025)
• Thermo Fisher launched IoT-enabled ULT system with predictive maintenance (Q4 2024)
• PHC Holdings revealed low-energy twin-guard freezer line (Q1 2025)
• Hamilton installed high-density automated storage system in France (Q2 2024)
• Brooks Life Sciences introduced blockchain-based tracking module (Q1 2025)
• WHO updated global best practices for biobank storage protocols (Q4 2024)
Strategic Outlook
• Manufacturers should invest in energy-efficient and AI-integrated systems to align with sustainability goals
• Collaboration with pharma firms and CROs will increase demand for hybrid storage systems
• Government funding and university partnerships will drive equipment standardization
• Expansion into mid-tier hospitals and developing country research centers presents untapped potential
Methodology
Clearview Market Insights gathered procurement data from international biobank networks, conducted 48 structured interviews with biorepository managers, and analyzed grant trends across 22 countries to forecast equipment demand.
About Clearview Market Insights
Clearview Market Insights provides targeted intelligence for laboratory infrastructure, biotechnology research, and digital healthcare integration, supporting decision-makers in advancing data-driven life science ecosystems.
• Understand how biobank technology is transforming research infrastructure
• Benchmark leading vendors and equipment adoption trends
• Identify growth regions for cryogenic and automation investments
• Stay informed on data compliance and storage traceability developments
• Revenue data (2019–2031) for major biobank equipment categories
• Breakdown by equipment type, sample type, end user, and region
• Company shares and strategic product launches
• Insights into LIMS and freezer innovations and sustainability trends
Need help?
Chat with our team in a minute.